Companies
ResMed
S&P 500Health Care· USA

RMD

Status-Quo-Player

ResMed

$230.26

+0.62%

Open $228.15·Prev $228.85

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

ResMed's moat is the integration of a dominant installed device base with a proprietary cloud data ecosystem that creates compounding switching costs across patients, clinicians, and payers simultaneously.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Lateral With Upward Bias as Fundamentals Diverge From Narrative

ROC 200

-11.0%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
RMD — ResMed — Power Mapping Analysis — L17X — L17X